Patents

US 9062103 B2: Adult stem cells/progenitor cells and stem cell proteins for treatment of eye injuries and diseases

Granted
2015-06-23
Filed
2014-04-11 application 14250807
Type
Utility · 5 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

The present invention encompasses methods and compositions for treating an ocular disease, disorder or condition in a mammal. The invention includes a population of mesenchymal stromal cells that possess anti-inflammatory, anti-apoptotic, immune modulatory and anti-tumorigenic properties. The invention includes administration of TSG-6, STC-1, or a combination thereof to the ocular as a treatment for an ocular disease, disorder or condition in a mammal.

Source: PVGPATDIS, file of 2026-04-10 (ipg150623.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
THE TEXAS A&M UNIVERSITY SYSTEM 801 patentsUS company or organizationCollege Station, TXPVGPATDIS, file of 2026-04-10
Temple Therapeutics BV 7 patentsForeign company or organizationFramingham, MAPVGPATDIS, file of 2026-04-10
SCOTT & WHITE HEALTHCARE 21 patentsUS company or organizationTemple, TXSCOTT & WHITE HEALTHCARE State business registration EXACT high confidence: identical full name and state
SCOTT & WHITE HEALTHCARE Nonprofit EXACT high confidence: identical full name and state
PVGPATDIS, file of 2026-04-10

Inventors

InventorPlacePatentsPerson pageSource
Darwin J. ProckopPhiladelphia, PA14PVGPATDIS, file of 2026-04-10
Joo Youn OhTemple, TX6PVGPATDIS, file of 2026-04-10
Barry BerkowitzFramingham, MA10PVGPATDIS, file of 2026-04-10
Gavin W. RoddyRochester, MN7Person page FUZZY medium confidencePVGPATDIS, file of 2026-04-10
Robert RosaBelton, TX7PVGPATDIS, file of 2026-04-10

CPC categories

SubclassCategoryFirst groupSource
A61KPreparations for medical, dental or toiletry purposesA61K35/28PVGPATDIS, file of 2026-04-10
A61PSpecific therapeutic activity of chemical compounds or medicinal preparationsA61P27/02PVGPATDIS, file of 2026-04-10
C07KPeptidesC07K16/18PVGPATDIS, file of 2026-04-10
C12NMicroorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture mediaC12N5/0663PVGPATDIS, file of 2026-04-10

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

RecordedWhatFromToReel/frameSource
2018-01-29Government interest
Confirmatory license
TEXAS A&M UNIVERSITY SYSTEM signed 2018-01-26NIH - DEITR BETHESDA, MD45181/60ECORSEXC, file of 2026-09-25

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.